Transaction · 0000874015-25-000085

O'NEIL PATRICK R.

O'NEIL PATRICK R., EC, GC, reported an open-market or private sale at IONIS PHARMACEUTICALS INC involving 6165.000000 shares for an estimated $194939.15. Reported holdings after the transaction were 57452.000000 shares. The stored filing text includes a detected 10b5-1 reference.

Open-market sellSEC transaction code SEC, GC
IONSIONIS PHARMACEUTICALS INC
Filing timeFeb 06
Trade dateFeb 04, 2025
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
…
Pre-filing
…
Returns since
…

IONS price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
IONS since 2025-02-06Filed 574 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
Sell
Code S
Identifier
0000874015-25-000085
Common Stock
Transaction date
Feb 04, 2025
Filed Feb 06, 2025, 11:27 PM · 2d delay
Shares
6.16k sh
$3.16k per share
Estimated value
-$19.4M
Computed from shares × price
Holdings after
57.4k sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Cluster Selling Direct Ownership Repeat Seller 10b5-1 Detected
0score
Filing-only score

0

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

EVP CLO & General Counsel

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on February 21, 2024.

  2. F2

    The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.56 to $31.715 inclusive. The reporting person undertakes to prov…

Original filing · 0000874015-25-000085
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

IONS